IPSEN PHARMA

IPSEN PHARMA

SIREN 308197185

Active

What the register says about IPSEN PHARMA

IPSEN PHARMA is registered under SIREN number 308197185. Its registered office is located at 70 RUE BALARD, 75015 PARIS. The company was founded on 15/10/1984. It declares that it operates in the Commerce de gros (commerce interentreprises) de produits pharmaceutiques sector. It is currently listed as active in the national business register.

BODACC has published 74 notices concerning it, the most recent dated 09/05/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

13 directors are published in the register. They are BERY, BROWN, HUGUET, JOHNSON, LE CHATELIER.

Identity : IPSEN PHARMA

IPSEN PHARMA

SIREN
308197185
Head office SIRET
30819718500124
Legal form
SAS (société par actions simplifiée)
NAF code
46.46Z · Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Address
70 RUE BALARD, 75015 PARIS
Creation date
10/15/1984
Category
GE
Status
Active
VAT
FR80308197185
Filing
05/09/2026
Closing
12/31/2025

Recent notices (74)

All legal notices

Web presence : IPSEN PHARMA

The company's official website, its networks and online contact details.

Recent notices : IPSEN PHARMA

The BODACC notices published for this company.

Directors : IPSEN PHARMA

The people who run or have run the company.

Relations : IPSEN PHARMA

The relationship graph: linked notices, people and companies.

Public contracts : IPSEN PHARMA

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : IPSEN PHARMA

Frequently asked questions and the company's filing history.

Frequently asked questions : IPSEN PHARMA

Deposit filing history

10 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 12/31/2025.